<SEC-DOCUMENT>0001193125-25-137866.txt : 20250609
<SEC-HEADER>0001193125-25-137866.hdr.sgml : 20250609
<ACCEPTANCE-DATETIME>20250609163243
ACCESSION NUMBER:		0001193125-25-137866
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250609
DATE AS OF CHANGE:		20250609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATURES SUNSHINE PRODUCTS INC
		CENTRAL INDEX KEY:			0000275053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				870327982
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287882
		FILM NUMBER:		251034592

	BUSINESS ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		(801) 341-7900

	MAIL ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMTEC INDUSTRIES INC
		DATE OF NAME CHANGE:	19821108
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d78153ds3.htm
<DESCRIPTION>S-3
<TEXT>
<HTML><HEAD>
<TITLE>S-3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on June&nbsp;9, 2025 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-&#8195;&#8195;&#8195;</FONT> </B></P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>Nature&#146;s Sunshine Products, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Utah</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">87-0327982</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2901 West Bluegrass Blvd., Suite 100 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Lehi, Utah 84043 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(801) <FONT
STYLE="white-space:nowrap">341-7900</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of
registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Nathan Brower </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>EVP, General
Counsel and Corporate Secretary </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2901 West Bluegrass Blvd., Suite 100 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Lehi, Utah 84043 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(801) <FONT
STYLE="white-space:nowrap">341-7900</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent
for service) </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>David F.
Marx </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Dan Lyman </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Dorsey&nbsp;&amp; Whitney LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>111 S. Main Street, Suite 2100 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Salt Lake City, Utah 84111 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(801) <FONT STYLE="white-space:nowrap">933-7360</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B><I>Approximate date of commencement of proposed sale to public:</I></B> From time to time after this Registration Statement becomes effective. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following
box.&#8194;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&#8194;&#9746; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is
a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744;
</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing
with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.&#8194;&#9744; </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&#8194;&#9744; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of Securities Act.&#8194;&#9744; </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on
such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative; overflow:visible; width:651pt; height:30pt; transform-origin:bottom left; transform: rotate(-90deg) translate(-100%, 100%) translateX(30pt);">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
</B></FONT></P></DIV><DIV STYLE="position:relative; overflow:visible; margin-left:48pt; margin-right:48pt; transform: translateY(-30pt);"> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>SUBJECT TO COMPLETION, DATED JUNE&nbsp;9, 2025 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g78153g00l03.jpg" ALT="LOGO" STYLE="width:3.15365in;height:0.924479in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Nature&#146;s Sunshine Products, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>2,854,607 Common Shares </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Offered by Selling Stockholder </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus relates to the offering and resale, from time to time, by the selling stockholder identified herein of up to 2,854,607 common shares acquired
by the Selling Stockholder&nbsp;as the current beneficial transferee of our common shares originally acquired by its affiliate&nbsp;(i) in a private placement of our common shares, or (ii)&nbsp;upon the exercise or vesting of previously issued
awards granted under a compensatory plan or arrangement with us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of common shares by the Selling
Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are registering the common shares on behalf of the Selling Stockholder, and the Selling Stockholder may sell all or a portion of the
common shares beneficially owned by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers, or agents. The Selling Stockholder may offer the shares at prevailing market prices or privately negotiated
prices. Please see the section entitled &#147;Plan of Distribution&#148; on page&nbsp;12 of this prospectus for more information. For information on the Selling Stockholder, see the section entitled &#147;Selling Stockholder&#148; on page&nbsp;11 of
this prospectus. We will bear all fees and expenses incident to our obligation to register the common shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common shares are listed on The Nasdaq
Capital Market under the symbol &#147;NATR&#148;. On June&nbsp;6, 2025, the last reported sale price for our common shares was $14.51 per share. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>INVESTING IN OUR SECURITIES INVOLVES SIGNIFICANT RISKS. YOU SHOULD REVIEW CAREFULLY THE &#147;<A HREF="#tx78153_3">RISK FACTORS</A>&#148;
ON PAGE 4 OF THIS PROSPECTUS AND CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT AND ANY RELATED FREE WRITING PROSPECTUS AND UNDER SIMILAR HEADINGS IN THE OTHER DOCUMENTS THAT ARE INCORPORATED BY REFERENCE INTO THIS PROSPECTUS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is
&#8195;&#8195;&#8195;, 2025 </B></P></DIV> <p STYLE="clear:both; font-size:1pt; height:0">&nbsp;</p>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_1">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_2">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_4">Cautionary Note Regarding Forward-looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_6">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_7">Selling Stockholder</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_8">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_9">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_10">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_11">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx78153_12">Information Incorporated by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information provided in this prospectus, as well as the information incorporated by reference
into this prospectus and any applicable prospectus supplement. We have not authorized anyone to provide you with different information. We are not making an offer of these securities in any jurisdiction where the offer is not permitted. You should
not assume that the information in this prospectus, any applicable prospectus supplement or any documents incorporated by reference is accurate as of any date other than the date of the applicable document. Since the respective dates of this
prospectus and the documents incorporated by reference into this prospectus, our business, financial condition, results of operations and prospects may have changed. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or incorporated by reference in this prospectus and any prospectus supplement or free writing prospectus
relating to a particular offering. No person has been authorized to give any information or make any representations in connection with this offering other than those contained or incorporated by reference in this prospectus, any accompanying
prospectus supplement and any related free writing prospectus in connection with the offering described herein and therein, and, if given or made, such information or representations must not be relied upon as having been authorized by us and/or the
Selling Stockholder. Neither this prospectus nor any prospectus supplement nor any related free writing prospectus shall constitute an offer to sell or a solicitation of an offer to buy offered securities in any jurisdiction in which it is unlawful
for such person to make such an offering or solicitation. This prospectus does not contain all of the information included in the registration statement. For a more complete understanding of the offering of the securities, you should refer to the
registration statement, including its exhibits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read the entire prospectus and any prospectus supplement and any related free writing
prospectus, as well as the documents incorporated by reference into this prospectus or any prospectus supplement or any related free writing prospectus, before making an investment decision. Neither the delivery of this prospectus or any prospectus
supplement or any free writing prospectus nor any sale made hereunder shall under any circumstances imply that the information contained or incorporated by reference herein or in any prospectus supplement or free writing prospectus is correct as of
any date subsequent to the date hereof or the date of such prospectus supplement or free writing prospectus, as applicable. You should assume that the information appearing in this prospectus, any prospectus supplement or any document incorporated
by reference is accurate only as of the date of the applicable documents, regardless of the time of delivery of this prospectus or any sale of securities. Our business, financial condition, results of operations and prospects may have changed since
that date.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_2"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary description about us and our business highlights selected information contained elsewhere in this prospectus or incorporated in this
prospectus by reference. This summary does not contain all of the information you should consider before buying securities in this offering. You should carefully read this entire prospectus and any applicable prospectus supplement, including each of
the documents incorporated herein or therein by reference, before making an investment decision. Unless the context otherwise requires, the terms &#147;Nature&#146;s Sunshine,&#148; &#147;NATR,&#148; &#147;the Company,&#148; &#147;the
Registrant,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; in this prospectus refer to Nature&#146;s Sunshine Products, Inc., and its subsidiaries. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a natural health and
wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force
of independent consultants who resell our products to consumers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have four business segments (Asia, Europe, North America and Latin America and Other)
based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#146;s Sunshine Products and Synergy WorldWide
brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities, independent of the Company, to whom we have granted distribution rights for the relevant market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management
and other general health products. We purchase herbs and other raw materials in bulk, and after quality control testing, we formulate, encapsulate, tablet or concentrate them, label and package them for shipment. Most of our products are
manufactured at our facility in Spanish Fork, Utah. Contract manufacturers produce some of our products in accordance with our specifications and standards. We have implemented quality control procedures to verify that our contract manufacturers
have complied with our specifications and standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We market our products primarily through our network of independent consultants, who market our
products to customers through direct selling techniques. We seek to motivate and provide incentives to our independent consultants by offering high quality products and providing independent consultants with product support, training seminars, sales
conventions, travel programs and financial incentives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our products sold in the United States are shipped directly from our manufacturing and warehouse
facilities located in Spanish Fork, Utah, as well as from our regional warehouses located in Georgia, Ohio and Texas. Many of our international operations maintain warehouse facilities and inventory to supply their independent consultants. However,
in foreign markets where we do not maintain warehouse facilities, we have contracted with third-parties to distribute our products and provide support services to our force of independent consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conduct research at our research center, known as the Hughes Center for Research and Innovation, a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> research and development facility located at our corporate offices in Lehi, Utah. Our principal emphasis in our research and development activities is
clinical research in the support of the development of new products and the enhancement of existing products. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are incorporated in the state of Utah. Our principal executive offices are located at 2901 West Bluegrass Blvd., Suite 100, Lehi, Utah 84043. Our telephone
number is (801) <FONT STYLE="white-space:nowrap">341-7900.</FONT> Our Internet address is www.naturessunshine.com. Information contained on our website or that is accessible through our website should not be considered to be part of this prospectus.
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Issuer</B> </P></TD>
<TD>Nature&#146;s Sunshine Products, Inc., a Utah corporation </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Securities offered by the Selling Stockholder</B> </P></TD>
<TD>2,854,607 common shares acquired by the Selling Stockholder&nbsp;as the current beneficial transferee of our common shares originally acquired by its affiliate (i)&nbsp;in a private placement of our common shares, and (ii)&nbsp;upon the exercise
or vesting of previously issued awards granted under a compensatory plan or arrangement with us. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common shares outstanding</B> </P></TD>
<TD>18,463,179 shares as of June&nbsp;9, 2025 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Use of proceeds</B> </P></TD>
<TD>We will not receive any of the proceeds from the sale of the shares being offered by the Selling Stockholder. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Risk Factors</B> </P></TD>
<TD>Investing in our securities involves a high degree of risk. See &#147;Risk Factors&#148; beginning on page&nbsp;4 and other information included and incorporated by reference in this prospectus for a discussion of factors that you should
carefully consider before deciding to invest in our common shares. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Listing</B> </P></TD>
<TD>Our common shares are listed on Nasdaq Capital Market under the symbol &#147;NATR.&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of common shares to be outstanding
immediately after this offering is based on 18,463,179 common shares outstanding as of June&nbsp;9, 2025 and excludes (in each case as of June&nbsp;9, 2025): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">25,000 common shares issuable upon the exercise of stock options outstanding with a weighted average exercise
price of $13.50 per share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,497,685 common shares issuable upon the vesting of outstanding restricted stock units. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the
risks described below and discussed under this section, together with other information in this prospectus and the documents incorporated by reference in this prospectus, including the information set forth under the
caption</I><I></I>&nbsp;&#147;<I>Risk Factors</I>&#148;<I></I><I>&nbsp;in our annual report on Form</I><I></I><I><FONT STYLE="white-space:nowrap">&nbsp;10-K</FONT></I><I></I><I>&nbsp;for the fiscal year ended December</I><I></I><I>&nbsp;31, 2024. If
any of these risks actually occurs, our business, financial condition or results of operations could be seriously harmed. This could cause the trading price of our common shares to decline, resulting in a loss of all or part of your investment.</I>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read and consider risk factors specific to our business before making an investment decision. Those risks are described below and in the
sections entitled &#147;Risk Factors&#148; in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;for</FONT> the fiscal year ended December&nbsp;31, 2024, and in other documents incorporated by reference into this prospectus.
Please be aware that additional risks and uncertainties not currently known to us or that we currently deem to be immaterial could also materially and adversely affect our business, results of operations, financial condition, cash flows or
prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to this Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You
may experience future dilution as a result of future equity offerings or other equity issuances. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To raise additional capital, we may in the future
offer additional common shares, preferred stock, or other securities convertible into or exchangeable for our common shares. We cannot assure you that we will be able to sell shares or other securities in any other offering at a price per share that
is equal to or greater than the price per share paid by investors in this offering. The price per share at which we sell additional common shares or other securities convertible into or exchangeable for our common shares in future transactions may
be higher or lower than the price per share in this offering. Investors purchasing shares or other securities in the future could have rights superior to existing stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales of our common shares in the public market could cause our stock price to fall. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of our common shares in the public market, or the perception that these sales might occur, could depress the market price of our
common shares, and could impair our ability to raise capital through the sale of additional equity securities. As of June&nbsp;9, 2025, we had 18,463,179 common shares outstanding, all of which were eligible for sale in the public market, subject in
some cases to compliance with the requirements of Rule 144, including the volume limitations and manner of sale requirements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Return on securities
is not guaranteed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no guarantee that the common shares will earn any positive return in the short term or long term. A holding of any
such security is speculative and involves a high degree of risk and should be undertaken only by holders whose financial resources are sufficient to enable them to assume such risks and who have no need for immediate liquidity in their investment.
An investment in the common shares is appropriate only for holders who have the capacity to absorb a loss of some or all of their investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_4"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus supplement contain certain
statements that constitute &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933 (the &#147;Securities Act&#148;) and Section&nbsp;21E of the Securities Exchange Act of 1934 (the &#147;Exchange
Act&#148;). The words &#147;anticipate,&#148; &#147;could,&#148; &#147;expect,&#148; &#147;believe,&#148; &#147;goal,&#148; &#147;plan,&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;may,&#148; &#147;seek,&#148; &#147;potential,&#148;
&#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;would,&#148; &#147;will,&#148; and similar expressions and variations thereof are intended to identify forward-looking statements, but are not the exclusive means of identifying
such statements. Those statements appear in this prospectus, any accompanying prospectus supplement and the documents incorporated herein and therein by reference, particularly in the sections entitled &#147;Prospectus Summary,&#148; &#147;Risk
Factors,&#148; &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and &#147;Business,&#148; and include statements regarding the intent, belief or current expectations of the Company and
management that are subject to known and unknown risks, uncertainties and assumptions and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such
forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed in the section titled &#147;Risk Factors&#148; set forth above, as well as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to comply with laws and regulations relating to trade restrictions and export controls;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">laws and regulations regarding direct selling that may prohibit or restrict our ability to sell our products in
some markets or require us to make changes to our business model in some markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current and potential future extensive government regulations to which the Company&#146;s products, business
practices and manufacturing activities are subject; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">registration of products for sale in foreign markets, or difficulty or increased cost of importing products into
foreign markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">legal challenges to the Company&#146;s direct selling program or to the classification of its independent
consultants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure of the Company&#146;s independent consultants to comply with advertising laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product liability claims; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to attract and retain independent consultants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the loss of one or more key independent consultants who have a significant sales network; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential for increased liability and compliance costs relating to the Company&#146;s joint venture for
operations in China with Fosun Industrial Co., Ltd.; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of fluctuating foreign exchange rates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liabilities and obligations arising from improper activity by the Company&#146;s independent consultants;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes to the Company&#146;s independent consultant compensation plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">geopolitical issues, conflicts or other global events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negative consequences resulting from difficult economic conditions, including the availability of liquidity or
the willingness of the Company&#146;s customers to purchase products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks associated with the manufacturing of the Company&#146;s products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">supply chain disruptions, manufacturing interruptions or delays or the failure to accurately forecast customer
demand; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to timely and effectively obtain shipments of products from our suppliers and deliver products to our
independent consultants and customers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of shifting tariff regimes and trade policies between U.S. and the other countries where we operate;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uncertainties relating to the application of transfer pricing, duties, value-added taxes and other tax
regulations, and changes thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to maintain an effective system of internal controls over financial reporting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cybersecurity threats and exposure to data loss; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the storage, processing and use of data, some of which contain personal information, are subject to complex and
evolving privacy and data protection laws and regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reliance on information technology infrastructure; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sufficiency of trademarks and other intellectual property rights. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and the information incorporated by reference in this prospectus and any prospectus supplement also contain
statements that are based on management&#146;s current expectations and beliefs, including estimates and projections about our company, industry, financial condition, results of operations and other matters. These statements are not guarantees of
future performance and are subject to numerous risks, uncertainties, and assumptions that are difficult to predict. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because forward-looking statements
are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking
statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, including the securities laws of the United States and the rules and
regulations of the SEC, we do not plan to publicly update or revise any forward-looking statements contained herein after we distribute this prospectus, whether as a result of any new information, future events or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of common shares being offered by the Selling Stockholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_6"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description summarizes the most important terms of our capital stock and does not purport to be complete and is qualified in its entirety by the
provisions of our Amended and Restated Articles of Incorporation (the &#147;Articles of Incorporation&#148;) and Amended and Restated Bylaws (the &#147;Bylaws&#148;), which documents are incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and the applicable provisions of the Utah Revised Business Corporation Act (the &#147;Revised Act&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized Shares of Capital Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized
capital stock consists of 50,000,000 common shares, no par value per share, and 10,000,000 preferred shares, no par value per share. As of June&nbsp;9, 2025, there were 18,463,179 common shares issued and outstanding and no preferred shares issued
and outstanding. The outstanding common shares are duly authorized, validly issued, fully paid, and nonassessable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common shares are listed and principally traded on the Nasdaq Capital Market under the symbol &#147;NATR&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder of common shares is entitled
to one (1)&nbsp;vote for each share held of record by such holder on the applicable record date on all matters submitted to a vote of common shareholders. The holders of common shares do not have cumulative voting rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of common shares are
entitled to receive dividends from funds legally available therefor, when and if declared, on such conditions and at such times as the board of directors may designate, provided, however, that no dividends shall be made with respect to the common
shares until any preferential dividends required to be paid or set apart for any preferred shares have been paid or set apart. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rights upon Liquidation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to any prior or superior rights of liquidation as may be conferred upon any preferred shares, and after payment or provision for payment of
the debts and other liabilities of the Company, upon any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of common shares then outstanding shall be entitled to receive all of the assets and
funds of the Company remaining and available for distribution. Such assets and funds shall be divided among and paid to the holders of common shares, on a <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis, according to the number of common
shares held by them. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Rights and Preferences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Articles of Incorporation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation
provide that no holder of shares of the Company of any class now or hereafter authorized, shall, as a holder of such shares, have any preferential or <FONT STYLE="white-space:nowrap">pre-emptive</FONT> right to subscribe for, purchase or receive any
shares of the Company of any class, now or hereafter authorized, or any options or warrants for such shares, or any rights to subscribe to or purchase such shares or any securities convertible into or exchangeable for such shares, which may at any
time be issued, sold or offered for sale by the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Fosun Preemptive Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to that certain Stockholder Agreement dated June&nbsp;26, 2014 between the Company and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#147;Fosun
Pharma&#148;), Fosun Pharma has the right to purchase its pro rata share of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any equity securities offered for sale by the Company, subject to certain limited exceptions. Fosun Pharma&#146;s pro rata share is based on the ratio that the number of common shares held by
Fosun Pharma bears to the total number of common shares outstanding immediately prior to such offering. The foregoing description of the Stockholder Agreement does not purport to be complete and is qualified in its entirety by reference to the full
text of the Stockholder Agreement, a copy of which is attached hereto as Exhibit 4.8. Pursuant to that certain Joinder Agreement dated June 9, 2025 executed as between Fosun Pharma and Fosun USA (which Joinder Agreement was perfected in light of the
May&nbsp;10, 2025 Share Purchase Agreement between the same), Fosun USA is the present obligor to the aforementioned Stockholder Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred
Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preferred shares may be issued from time to time, in one or more series, as authorized by our board of directors. Prior to the issuance of
shares of each series, the board of directors is required by the Revised Act and our Articles of Incorporation to fix, for each series, the designations, powers and preferences and the relative, participating, optional or other special rights of the
shares of each series and any qualifications, limitations and restrictions thereof, as are permitted by Utah law. Our board of directors could authorize the issuance of preferred shares with terms and conditions that could have the effect of
discouraging a takeover or other transactions that holders of common shares might believe to be in their best interests or in which holders of some, or a majority, of the common shares might receive a premium for their shares over the then market
price of such common shares. When issued, the preferred shares will be fully paid and nonassessable and will have no preemptive rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we decide to
issue any preferred shares pursuant to this prospectus, we will describe in a prospectus supplement the terms of the preferred shares, including, if applicable, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the series and stated value; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares of the series of preferred shares offered, the liquidation preference per share, if
applicable, and the offering price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the applicable dividend rate(s) or amount(s), period(s) and payment date(s) or method(s) of calculation thereof;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date from which dividends on the preferred shares will accumulate, if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any procedures for auction and remarketing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions for a sinking fund; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable provision for redemption and the price or prices, terms and conditions on which preferred shares
may be redeemed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any securities exchange listing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any voting rights and powers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether interests in the preferred shares will be represented by depositary shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms and conditions, if applicable, of conversion into common shares, including the conversion price or rate
or manner of calculation thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a discussion of any material U.S. federal income tax considerations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the relative ranking and preference as to dividend rights and rights upon our liquidation, dissolution or the
winding up of our affairs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limitations on issuance of any series of preferred shares ranking senior to or on a parity with such series
of preferred shares as to dividend rights and rights upon our liquidation, dissolution or the winding up of our affairs; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms, preferences, rights, limitations or restrictions of such series of preferred shares.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Stock Transfer is the transfer agent and registrar for our common shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Anti-Takeover Effects </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain provisions of our
Articles of Incorporation and Bylaws may be deemed to have an anti-takeover effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advance Notice Requirements for Shareholder Proposals and Director
Nominations. </I>Our Bylaws provide advance notice procedures for shareholders seeking to bring business before our annual meeting of shareholders or to nominate candidates for election as directors at our annual meeting of shareholders and specify
certain requirements regarding the form and content of a shareholder&#146;s notice. These provisions might preclude our shareholders from bringing matters before our annual meeting of shareholders or from making nominations for directors at our
annual meeting of shareholders if the proper procedures are not followed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Additional Authorized Shares of Capital Stock. </I>The additional shares of
authorized common shares and preferred shares available for issuance under our Articles of Incorporation, could be issued at such times, under such circumstances and with such terms and conditions as to impede a change in control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Issuance of Undesignated Preferred Shares. </I>Our board of directors has the authority, without further action by the shareholders, to issue shares of
undesignated preferred shares with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued preferred shares would enable our board of directors to render more
difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitations on
Stockholder Ability to Act by Written Consent or Call Special Meetings. </I>The Articles of Incorporation eliminate the right of shareholders to act by written consent without a meeting. Further, the Bylaws provide that special meetings of
shareholders may be called only by the board of directors acting pursuant to a resolution adopted by a majority of the board of directors or by the Secretary, following his or her receipt of one or more written demands to call a special meeting from
shareholders of record who hold, in the aggregate, at least ten percent (10%) of the voting power of the outstanding shares of the corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_7"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus relates to the possible resale by certain of our stockholders, who we refer to in this prospectus as the &#147;Selling Stockholder,&#148; of
up to 2,854,607 common shares that were issued and outstanding prior to the original date of filing of the registration statement of which this prospectus forms a part. The Selling Stockholder is the current beneficial transferee of common shares
which were originally acquired by its affiliate, and which common shares are included in this prospectus (i)&nbsp;in a private placement of our common shares, or (ii)&nbsp;upon the exercise or vesting of previously issued awards granted under a
compensatory plan or arrangement with us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below lists the Selling Stockholder and other information regarding the beneficial ownership of the
common shares by the Selling Stockholder. The second column lists, as of June&nbsp;9, 2025, the number of common shares beneficially owned by the Selling Stockholder based on its ownership of common shares and other securities exercisable for common
shares. The third column lists the common shares being offered by the Selling Stockholder under this prospectus. The fourth column assumes the sale of all of the shares offered by the Selling Stockholder pursuant to this prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name of Selling</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>shares of</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Common</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Stock<BR>Owned</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Prior
to</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum<BR>Number&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>shares of<BR>Common<BR>Stock</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be Sold<BR>Pursuant&nbsp;to</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>this&nbsp;Prospectus</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>shares of</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Common</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Stock<BR>Owned</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>After</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering</B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Percentage&nbsp;of<BR>Shares of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Common<BR>Stock</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Beneficially<BR>Owned<BR>After</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fosun Pharma USA, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,854,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,854,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Transactions with the Selling Stockholder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a description of other transactions with the Selling Stockholder during the past three years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;25, 2014, we completed a transaction with Fosun Pharma, which created a joint venture owned 80&nbsp;percent by us and 20&nbsp;percent by a
wholly owned subsidiary of Fosun Pharma. The joint venture, known as Nature&#146;s Sunshine Hong Kong Limited, markets and distributes Nature&#146;s Sunshine products in China. As part of this transaction, the Company issued to Fosun Pharma
2,854,607 common shares. In connection with this transaction, the Company entered into a Stockholder Agreement with Fosun Pharma (the &#147;Stockholder Agreement&#148;), which, among other things, provides that the Company will register the common
shares issued to Fosun Pharma, at the request of Fosun Pharma. The Company is filing this Registration Statement at the request of Fosun Pharma pursuant to its registration rights under the Stockholder Agreement. The Stockholder Agreement also
provides that if Fosun Pharma, together with its affiliates, ceases to own at least 5% of the outstanding shares of the Company&#146;s common shares, Fosun Pharma will sell to the Company, and the Company will purchase, Fosun Pharma&#146;s interests
in Nature&#146;s Sunshine Hong Kong Limited. The Stockholder Agreement will terminate upon the earlier of (i)&nbsp;all of the Selling Stockholder&#146;s shares are no longer &#147;Registrable Securities&#148; (as defined in the Stockholder
Agreement) or the selling stockholder is no longer an &#147;Affiliated Entity&#148; (as defined in the Stockholder Agreement), (ii) the Company is no longer reporting, or subject to reporting requirements, under the Exchange Act, or (iii)&nbsp;less
than 500,000 of the shares initially issued to Fosun Pharma are held by the Selling Stockholder and any Affiliated Entity (as defined in the Stockholder Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 9, 2025, pursuant to a Share Purchase Agreement executed as between the parties, Fosun Pharma agreed to the sale of the aforementioned 2,854,607
common shares to Fosun Pharma USA Inc. (&#147;Fosun USA&#148;), with all right and title in and to those shares, as well as succession to all of the rights and obligations otherwise falling to a shareholder of the same pursuant to the aforementioned
Stockholder Agreement, being transferred to Fosun USA pursuant thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rong Yang, who has served on our board of directors since June 2022, served as
CEO of Fosun USA from December 2021 through May 2025. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_8"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Selling Stockholder and any of its pledgees, assignees
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">and&nbsp;successors-in-interest&nbsp;may,</FONT></FONT> from time to time, sell any or all of its securities covered hereby on the Nasdaq Capital Market or any other stock exchange,
market, or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholder may use any one or more of the following methods when selling securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">one or more underwritten offerings on a firm commitment or best-efforts basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the&nbsp;broker-dealer&nbsp;will attempt to sell the securities as agent but may position
and resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a&nbsp;broker-dealer&nbsp;as principal and resale by the&nbsp;broker-dealer&nbsp;for its account;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions through&nbsp;broker-dealers&nbsp;that agree with the Selling Stockholder to sell a specified
number of such securities at a stipulated price per security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Selling Stockholder may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than
under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of
distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If underwriters are used in a sale, they will acquire the offered common shares for their own account. The underwriters may resell the
offered securities in one or more transactions, including negotiated transactions. The Selling Stockholder may offer the common shares to the public either through an underwriting syndicate represented by one or more managing underwriters or through
one or more underwriter(s). The underwriters in any particular offering will be identified in the applicable prospectus supplement or pricing supplement, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in connection with any particular offering of common shares, the obligations of the underwriters to purchase the offered common
shares will be subject to certain conditions contained in an underwriting agreement that we and the Selling Stockholder will enter into with the underwriters at the time of the sale to them. The underwriters will be obligated to purchase all common
shares offered if any of the common shares are purchased, unless otherwise specified in connection with any particular offering. Any initial offering price and any discounts or concessions allowed, reallowed or paid to underwriters may be changed
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Broker-dealers&nbsp;engaged by the Selling Stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers
may receive commissions or discounts from the Selling Stockholder (or, if any&nbsp;broker-dealer&nbsp;acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this
Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the sale of the securities or interests therein, the Selling Stockholder may enter into
hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholder may also sell securities short and
deliver these securities to close out its short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholder may also enter into option or other transactions with broker-dealers or
other financial institutions or create one or more derivative securities that require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial
institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Selling Stockholder and any
broker-dealers or agents that are involved in selling the securities may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. The Selling Stockholder has informed us that it does not have any written or oral
agreement or understanding, directly or indirectly, with any person to distribute the securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will bear all fees and expenses incident to our
obligation to register the common shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The resale securities will be sold only through registered or licensed brokers or dealers if required under
applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or
qualification requirement is available and is complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under applicable rules and regulations under the Exchange Act, any person engaged in the
distribution of the resale securities may not simultaneously engage in market making activities with respect to the common shares for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In
addition, the Selling Stockholder will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common shares by the Selling
Stockholder or any other person. We will make copies of this prospectus available to the Selling Stockholder and have informed it of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by
compliance with Rule 172 under the Securities Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_9"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain legal matters, including the legality of the securities offered, will be passed upon for us by our counsel, Dorsey&nbsp;&amp; Whitney LLP, Salt Lake
City, Utah. If the securities are distributed in an underwritten offering, certain legal matters will be passed upon for the underwriters by counsel identified in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_10"></A>EXPERTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
financial statements incorporated in this Prospectus by reference from the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> and the effectiveness of Nature&#146;s Sunshine Products, Inc.&#146;s internal control over
financial reporting have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their reports, which are incorporated herein by reference. Such financial statements have been so incorporated in
reliance upon the reports of such firm given upon their authority as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_11"></A>WHERE
YOU CAN FIND MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are
available to the public over the Internet at the SEC&#146;s website at <I>http://www.sec.gov</I>. The SEC&#146;s website contains reports, proxy and information statements and other information regarding issuers, such as us, that file electronically
with the SEC. The reports and other information filed by us with the SEC are also available at our website, <I>https://ir.naturessunshine.com. </I>Information contained on our website or that can be accessed through our website is not incorporated
by reference into this prospectus or any prospectus supplement and should not be considered to be part of this prospectus or any prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the SEC. The registration statement contains more information than this prospectus
regarding us and our common shares, including certain exhibits and schedules. You can obtain a copy of the registration statement from the SEC&#146;s Internet site. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx78153_12"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate&#148; into this prospectus information that we file with the SEC in other documents. This means that we can disclose
important information to you by referring to other documents that contain that information. Any information that we incorporate by reference is considered part of this prospectus. The documents and reports that we list below are incorporated by
reference into this prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will automatically update and supersede information contained in this prospectus, including
information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed the following documents with the SEC. These documents are incorporated herein by reference as of their respective dates of filing: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000162828025012082/natr-20241231.htm">Annual
 Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended December&nbsp;31, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarter ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000162828025022765/natr-20250331.htm">March
<U></U>&nbsp;31, 2025</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000162828025004020/natr-20250130.htm">February
<U></U>&nbsp;5, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000162828025011764/natr-20250304.htm">March<U></U>&nbsp;
11, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000162828025022734/natr-20250430.htm">May<U></U>&nbsp;6,&nbsp;
2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000162828025028851/natr-20250528.htm">June<U></U>&nbsp;2, 2025</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the description of our common shares contained in our <A HREF="http://www.sec.gov/Archives/edgar/data/0000275053/000110465909057987/a09-30145_18a12b.htm">Registration
 Statement on Form <FONT STYLE="white-space:nowrap">8-A</FONT></A> as filed with the SEC on October&nbsp;6, 2009 pursuant to Section&nbsp;
12(b) of the Exchange Act, as updated by the description of our common shares contained in <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000275053/000027505321000011/natr-20201231.htm#i14116e0011cb4e549a3644a195b5c4f5_81">Exhibit
 4.1</A>&nbsp;to our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K/A&nbsp;for</FONT> the fiscal year ended December&nbsp;31, 2020, filed with the SEC on July&nbsp;9, 2021. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file with the SEC pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the
termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather
than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request, orally or upon written request, a copy of these documents, which will be provided to you at no cost, by contacting: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nature&#146;s Sunshine Products, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2901 West Bluegrass Blvd., Suite 100 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lehi, UT 84043 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Corporate
Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(801) <FONT STYLE="white-space:nowrap">341-7900</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in this prospectus, including information incorporated by reference as described above, or any prospectus
supplement that we have specifically referred you to. We have not authorized anyone else to provide you with different information. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date
other than the date on the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date. You should not consider this prospectus to be an offer or solicitation relating to the
securities in any jurisdiction in which such an offer or solicitation relating to the securities is not authorized. Furthermore, you should not consider this prospectus to be an offer or solicitation relating to the securities if the person making
the offer or solicitation is not qualified to do so, or if it is unlawful for you to receive such an offer or solicitation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g78153g00l03.jpg" ALT="LOGO" STYLE="width:3.15365in;height:0.924479in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Nature&#146;s Sunshine Products, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>2,854,607 Common Shares </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Offered by Selling Stockholder </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:80pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>, 2025 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;14. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The expenses in connection with the issuance and distribution of the securities being registered are set forth in the following table (all amounts except the
registration fee are estimated): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,260.60</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,260.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant is filing this registration statement to replace its existing registration statement (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-257823).</FONT> In accordance with Rule 457(p), effectiveness of this registration statement will be deemed to terminate such registration statement. A portion of the filing fee associated with this
registration statement was carried forward from the prior registration statement. Please see the registration fee table contained in Exhibit 107 to this registration statement for more information. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated expenses are not presently known. The foregoing sets forth the general categories of expenses (other
than underwriting discounts and commissions) that we anticipate we will incur in connection with the offering of securities under this registration statement. An estimate of the aggregate expenses in connection with the issuance and distribution of
the securities being offered will be included in the applicable prospectus supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;15. Indemnification of Directors
and Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant is a Utah corporation.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;16-10a-902</FONT></FONT> of the Revised Act provides that a corporation may indemnify any individual who was made a party (a &#147;Party&#148;) to a proceeding (a
&#147;Proceeding&#148;), because he or she is or was a director of the corporation (an &#147;Indemnifiable Director&#148;), against liability incurred in the Proceeding if his or her conduct was in good faith and he or she reasonably believed that
his or her conduct was in, or not opposed to, the best interests of the corporation, and, in the case of any criminal Proceeding, he or she had no reasonable cause to believe such conduct was unlawful; provided, however, that pursuant to Subsection
902(4): (i) the corporation may not indemnify an Indemnifiable Director in connection with a Proceeding by or in the right of the corporation in which the Indemnifiable Director was adjudged liable to the corporation, or in connection with any other
Proceeding charging that the Indemnifiable Director derived an improper personal benefit, whether or not involving action in his or her official capacity, in which Proceeding he or she was adjudged liable on the basis that he or she derived an
improper personal benefit; and, provided, further, however, that pursuant to Subsection 902(5) indemnification under Section&nbsp;902 in connection with a Proceeding by or in the right of the corporation is limited to payment of reasonable expenses
incurred in connection with the Proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;16-10a-903</FONT></FONT> of
the Revised Act provides that, unless limited by its articles of incorporation, a corporation shall indemnify an Indemnifiable Director who was successful, on the merits or otherwise, in the defense of any Proceeding, or in the defense of any claim,
issue or matter in the Proceeding, to which he or she was a Party because he or she is or was an Indemnifiable Director of the corporation, against reasonable expenses incurred in connection with the Proceeding or claim with respect to which he or
she has been successful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the indemnification provided by Sections 902 and 903, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Section&nbsp;16-10a-905</FONT></FONT> of the Revised Act provides that, unless otherwise limited by a corporation&#146;s articles of incorporation, an Indemnifiable Director
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may apply for indemnification to the court conducting the Proceeding or to another court of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;16-10a-904</FONT></FONT> of the Revised Act provides that a corporation may pay
for or reimburse the reasonable expenses (including attorneys&#146; fees) incurred by an Indemnifiable Director who is a Party to a Proceeding in advance of the final disposition of the Proceeding, upon the satisfaction of certain conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;16-10a-907</FONT></FONT> of the Revised Act and provides that, unless a
corporation&#146;s articles of incorporation provide otherwise, (i)&nbsp;an officer of the corporation is entitled to mandatory indemnification under Section&nbsp;903 and is entitled to apply for court-ordered indemnification under Section&nbsp;905,
in each case to the same extent as an Indemnifiable Director, (ii)&nbsp;the corporation may indemnify and advance expenses to an officer, employee, fiduciary or agent of the corporation to the same extent as an Indemnifiable Director, and
(iii)&nbsp;a corporation may also indemnify and advance expenses to an officer, employee, fiduciary or agent who is not an Indemnifiable Director to a greater extent than the right of indemnification granted to an Indemnifiable Director, if not
inconsistent with public policy, and if provided for by its articles of incorporation, bylaws, general or specific action of its board of directors, or contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant&#146;s Articles of Incorporation, authorize the Registrant to indemnify and advance expenses to its directors and officers to the fullest
extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Articles of Incorporation eliminate the personal liability of any director in accordance with
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;16-10a-841</FONT></FONT> of the Revised Act, which provides that the liability of a director to the corporation or its shareholders for monetary damages for any action
taken or any failure to take any action, as a director, may be limited or eliminated by the corporation except for liability for (i)&nbsp;the amount of financial benefit received by a director to which he or she is not entitled; (ii)&nbsp;an
intentional infliction of harm on the corporation or its shareholders; (iii)&nbsp;a violation of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;16-10a-842</FONT></FONT> of the Revised Act, which prohibits unlawful
distributions by a corporation to its shareholders; or (iv)&nbsp;an intentional violation of criminal law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant&#146;s Bylaws also provide
that, subject to certain limitations described in the Bylaws, the Registrant may, to the maximum extent and in the manner permitted in the Revised Act, indemnify an individual made a party to a proceeding because he or she is or was a director,
officer, employee, fiduciary, or agent of the Registrant against liability incurred in the proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws also provide that the Registrant may
pay for or reimburse the reasonable expenses incurred by director, officer, employee, fiduciary, or agent of the Registrant who is party to a proceeding in advance of final disposition of the proceeding if (i)&nbsp;such party furnishes to the
Registrant a written affirmation of his or her good faith belief that he or she has met the applicable standard of conduct under the Bylaws and applicable law necessary for indemnification, (ii)&nbsp;such party furnishes to the Registrant a written
undertaking in the form required by the Revised Act, executed personally or on his or her behalf, to repay the advance if it is ultimately determined that he or she did not meet the standard of conduct, and (iii)&nbsp;a determination is made that
the facts then known to those making the determination would not preclude indemnification pursuant to the Bylaws and applicable law. The Bylaws also provide that any indemnification or advancement of expenses provided thereby shall not be deemed
exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any articles of incorporation, bylaw, agreement, vote of shareholders or disinterested directors, or otherwise, both as to action
in such person&#146;s official capacity and as to action in another capacity while holding such office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws provide that the Registrant may
purchase and maintain insurance on behalf of any person who is or was one of the Registrant&#146;s directors, officers, employees, fiduciaries or agents, or is or was serving at the Registrant&#146;s request as a director, officer, employee,
fiduciary or agent of another foreign or domestic corporation or other person, or of an employee benefit plan, against liability incurred by him or her in such capacity or arising out of his or her status in such capacity, whether or not the
Registrant would have the power </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to indemnify him or her against such liability under applicable law. The Registrant maintains insurance from commercial carriers against certain liabilities that may be incurred by its directors
and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant has also entered into separate indemnification agreements with each of its directors and executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made to &#147;Undertakings,&#148; below, for the Registrant&#146;s undertakings in this registration statement with respect to indemnification of
liabilities arising under the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;16. Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits listed in the Exhibit Index below are filed as part of this registration statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;17. Undertakings. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned Registrant
hereby undertakes: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant
to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Filing Fee Tables&#148; or &#147;Calculation of Registration
Fee&#148; table, as applicable, in the effective registration statement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of
distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided, however</I>, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), that are
incorporated by reference in this Registration Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) That, for the purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial <I>bona fide</I> offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) That, for the purpose of determining liability under the Securities Act to any purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed
prospectus was deemed part of and included in the registration statement; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a
registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x)&nbsp;for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of
and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in
Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which
that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof. <I>Provided, however</I>, that no statement made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) That, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of the securities:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant undertakes that in a primary offering of securities of such undersigned Registrant pursuant to this
registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, such undersigned Registrant will be
a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) Any preliminary prospectus or prospectus of the
undersigned Registrant relating to the offering required to be filed pursuant to Rule 424; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) Any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) The portion of any other free writing
prospectus relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) Any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(6) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the
Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(7) Insofar as
indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the indemnification provisions described herein, or otherwise, the Registrant has been
advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Item&#8201;No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/275053/000162828018003302/natr-12312017xex31articles.htm">Amended and Restated Articles of Incorporation. </A>(included as Exhibit 3.1 to the Company&#146;s Quarterly Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> filed May&nbsp;10, 2021, and incorporated herein by reference).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/275053/000027505321000003/arbylawsmarch2021.htm">Amended and Restated Bylaws.</A> (included as Exhibit 3.2 to the Company&#146;s Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> filed on March&nbsp;11, 2021, and incorporated herein by reference).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;4.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/275053/000110465914049882/a14-16262_1ex10d2.htm">Stockholder Agreement dated June&nbsp;
26, 2014, between Nature&#146;s Sunshine Products, Inc. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd.</A> (included as Exhibit 10.2 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on July&nbsp;2,
2014, and incorporated herein by reference).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;*5.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d78153dex51.htm">Opinion of Dorsey&nbsp;&amp; Whitney LLP, counsel to the Registrant. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;10.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/275053/000110465914063790/a14-20165_2ex10d1.htm">Operating Agreement dated August<U></U>&nbsp;
25, 2014, among Nature&#146;s Sunshine Products, Inc., Fosun Industrial Co., Limited and Nature&#146;s Sunshine Hong Kong Limited.</A> (included as Exhibit 10.1 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT>
filed on August&nbsp;29, 2014, and incorporated herein by reference).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;10.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0000275053/000027505321000026/amendmenttooperatingagreem.htm">Amendment to Operating Agreement</A> (included as Exhibit 99.1 to the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed on August&nbsp;17, 2021, and incorporated herein by reference).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*23.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d78153dex51.htm">Consent of Dorsey&nbsp;&amp; Whitney LLP (included in Exhibit 5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*23.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d78153dex232.htm">Consent of Independent Registered Public Accounting Firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*24.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d78153ds3.htm#sig">Power of Attorney (contained in signature page). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*107</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d78153dexfilingfees.htm">Filing Fee Table </A></TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and has duly caused this registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> to be signed on its behalf by the undersigned, thereunto duly authorized,
in Lehi, Utah, on the 9th day of June, 2025. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>Nature&#146;s Sunshine Products, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: June&nbsp;9, 2025</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terrence O. Moorehead</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Terrence O. Moorehead,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Executive
Officer)</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Terrence O. Moorehead and L. Shane Jones
and each of them acting individually, as his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of each to act alone, with full powers of substitution
and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> with all exhibits thereto and
all documents in connection therewith, with the Securities and Exchange Commission, granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of each to act
alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all
that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, or his or their substitutes, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933 this report has been signed below by the following persons on behalf of the Registrant and in the
capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Terrence O. Moorehead</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Terrence O. Moorehead</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ L. Shane Jones</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">L. Shane Jones</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President, Chief Financial Officer and Treasurer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Financial Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan D. Lanoy</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Jonathan D. Lanoy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Vice President, Chief Accounting Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven J. Fasching</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Steven J. Fasching</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Curtis Kopf</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Curtis Kopf</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Katie A. May</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Katie A. May</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tess Roering</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Tess Roering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert D. Straus</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Robert D. Straus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Heidi Wissmiller</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Heidi Wissmiller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rong Yang</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Rong Yang</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">June&nbsp;9, 2025</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d78153dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g78153g0606101109372.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">June&nbsp;9, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nature&#146;s Sunshine Products, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2901 West Bluegrass
Blvd., Suite 100 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lehi, Utah 84043 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT></U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to Nature&#146;s Sunshine Products, Inc., a Utah corporation (the &#147;<U>Company</U>&#148;), in connection with a
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#147;<U>Registration Statement</U>&#148;) filed by the Company with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the Securities Act
of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), relating to the offer and sale by certain selling stockholders of up to 2,854,607 shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have examined such documents and have reviewed such questions of law as we have considered necessary or appropriate for the purposes of our
opinions set forth below. In rendering our opinions set forth below, we have assumed the authenticity of all documents submitted to us as originals, the genuineness of all signatures and the conformity to authentic originals of all documents
submitted to us as copies. We have also assumed the legal capacity for all purposes relevant hereto of all natural persons. As to questions of fact material to our opinions, we have relied upon certificates or comparable documents of officers and
other representatives of the Company and of public officials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, we are of the opinion that the Shares have been
validly issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions expressed above are limited to
the laws of the State of Utah. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement, and to the
reference to our firm under the heading &#147;Legal Matters&#148; in the prospectus constituting part of the Registration Statement. In giving this consent, we do not admit that we are within the category of persons whose consent is required under
Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Dorsey &amp; Whitney LLP</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DFM/DPL </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d78153dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
consent to the incorporation by reference in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> of our reports dated March&nbsp;11, 2025, relating to the financial statements of Nature&#146;s Sunshine Products, Inc. and
the effectiveness of Nature&#146;s Sunshine Products, Inc.&#146;s internal control over financial reporting, appearing in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of Nature&#146;s Sunshine Product, Inc. for the year
ended December&nbsp;31, 2024. We also consent to the reference to us under the heading &#147;Experts&#148; in such Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ DELOITTE
&amp; TOUCHE LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Salt Lake City, Utah </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;9, 2025
</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d78153dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Tables </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form <FONT STYLE="white-space:nowrap">S-3</FONT> </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Nature&#146;s
Sunshine Products, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Table 1: Newly Registered and Carry Forward Securities </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Security<BR>Type</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Security</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Class</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Fee<BR>Calculation&#8201;<BR>or Carry<BR>Forward<BR>Rule</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Amount<BR>Registered</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Proposed<BR>Maximum<BR>Offering<BR>Price Per<BR>Unit (2)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Maximum</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Aggregate</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offering</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Price</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Rate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Amount of<BR>Registration<BR>Fee</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Carry<BR>&#8201;Forward&#8201;<BR>Form<BR>Type</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Carry<BR>&#8201;Forward&#8201;<BR>File<BR>Number</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Carry<BR>&#8201;Forward&#8201;<BR>Initial<BR>Effective<BR>Date</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Filing
Fee<BR>Previously<BR>Paid In<BR>Connection<BR>&#8201;with&nbsp;Unsold&#8201;<BR>Securities<BR>to&nbsp;be</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Carried<BR>Forward</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="25" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="25" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt; padding-right:2pt">Newly Registered Securities</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Fees&nbsp;to&nbsp;Be&nbsp;Paid&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#8201;Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Common&nbsp;Shares,&nbsp;no&nbsp;par value per share (1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">457(c)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#8201;2,854,607&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#8201;14.235</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#8201;$40,892,245.28</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#8201;$0.00015310&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#8201;$6,260.60&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&#151;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Fees Previously Paid</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&#151;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="right" STYLE="padding-bottom:1pt ;">Total Offering Amounts&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">$40,892,245.28</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">$6,260.60</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="right" STYLE="padding-bottom:1pt ;">Total Fees Previously Paid&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="right" STYLE="padding-bottom:1pt ;">Total Fee Offsets&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">$5,487.63</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">Net Fee Due&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">$772.97</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the sum of up to 2,854,607 shares of Common Stock issued or issuable acquired by the Selling
Stockholder (i)&nbsp;in a private placement of our common stock, or (ii)&nbsp;upon the exercise or vesting of previously issued awards granted under a compensatory plan or arrangement with us. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration
fee, the proposed maximum offering price per share is the average of the high and low prices reported for the registrant&#146;s Class&nbsp;A Common Stock quoted on The Nasdaq Capital Market LLC on June&nbsp;2, 2025. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 2</B><B></B>&nbsp;-<B></B><B>&nbsp;Fee Offset Claims and Sources</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Registrant<BR>or Filer<BR>Name</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Form</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">or Filing<BR>Type</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">File<BR>Number</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Initial<BR>Filing</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Date</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Filing<BR>Date</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offset<BR>Claimed</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Security<BR>Type<BR>Associated<BR>with Fee<BR>Offset<BR>Claimed</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Security<BR>Title<BR>Associated<BR>with Fee<BR>Offset<BR>Claimed</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Unsold<BR>Securities<BR>Associated<BR>with Fee<BR>Offset<BR>Claimed</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Unsold<BR>Aggregate<BR>Offering<BR>Amount<BR>Associated<BR>with Fee<BR>Offset<BR>Claimed</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee&nbsp;Paid</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">with&nbsp;Fee</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offset</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Source</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="1" COLSPAN="23" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="23" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt; padding-right:2pt">Rule 457(p)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Fee Offset Claims</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Nature&#146;s Sunshine Products,&nbsp;Inc.</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">POS&nbsp;AM</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"><FONT STYLE="white-space:nowrap">333-257823</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">April&nbsp;17, 2024</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">$5,487.63</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Common Shares, no par value per share</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">Fees Offset Sources</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">Nature&#146;s Sunshine Products, Inc.</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">POS AM</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000"><FONT STYLE="white-space:nowrap">333-257823</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">April&nbsp;17, 2024</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$5,487.63</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 457(p) promulgated under the Securities Act, the registrant hereby offsets the total
registration fee due under this registration statement by $5,487.63, which represents a portion of the registration fee previously paid with respect to 2,854,607 common shares issued or issuable to the Selling Stockholder, all of which remain unsold
(the &#147;Unsold Securities&#148;). The Unsold Securities were previously registered pursuant to (a)&nbsp;the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-257823),</FONT> which was declared effective on August&nbsp;2, 2021 (the &#147;Prior Form <FONT STYLE="white-space:nowrap">S-3&#148;),</FONT> and (b)&nbsp;the Post-Effective Amendment No.&nbsp;1 to Form <FONT
STYLE="white-space:nowrap">S-3</FONT> on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-257823),</FONT> which was declared effective on April&nbsp;22, 2024 (together with the Prior Form <FONT
STYLE="white-space:nowrap">S-3,</FONT> the &#147;Prior Registration Statement&#148;). The registrant paid a filing fee of $5,487.63 associated with the offering of the Unsold Securities (based on the filing fee rate in effect at the time of the
filing of the Prior Form <FONT STYLE="white-space:nowrap">S-3).</FONT> The offering of securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g78153g00l03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g78153g00l03.jpg
M_]C_X  02D9)1@ ! 0$!@ &   #_[1K24&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 8     !  $!@     $  3A"24T$)@
M#@             _@   .$))300-       $    'CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #-0    8
M             6,   2[          $                          0
M           $NP   6,                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P   6,     4F=H=&QO;F<   2[    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   %C
M     %)G:'1L;VYG   $NP    -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$$0       0$
M.$))3004       $     3A"24T$#      0K     $   "@    +P   >
M %@@   0D  8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_;
M (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01
M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ +P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
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M1B[KOU<_5[<<;LG$!)JLK'NL]D_FM_P7_;'I7IS3$:!(!XH$\9B2,GA,?O\
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M@M +; )+7-.ZM\?G>X+F7="^NU^(.C79=#<  5NO$EYK'^#^@VQ_M_-]F_\
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M[-S"]S6C9Q_/?Z+]%^G_ .M;$LK/S<__ !=796=_/.#1ZA@;VMN8UEL?RO\
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M/;[M^[Z&U*T>R>*,M#PQC'7^J__9.$))300A      !5     0$    / $$
M9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(      2Y-30 J
M    "  ' 1(  P    $  0   1H !0    $   !B 1L !0    $   !J 2@
M P    $  @   3$  @   !X   !R 3(  @   !0   "0AVD !     $   "D
M    T    8     !   !@     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*0 R,#(U.C V.C V(# X.C(S.C$R   #H $  P    '__P  H ( !
M  $   2[H , !     $   %C          8! P #     0 &   !&@ %
M 0   1X!&P %     0   28!*  #     0 "   " 0 $     0   2X" @ $
M     0              2     $   !(     3A"24T#_0      "
M    _^$!-D5X:68  $U- "H    (  <!$@ #     0 !   !&@ %     0
M &(!&P %     0   &H!*  #     0 "   !,0 "    '@   '(!,@ "
M%    )"':0 $     0   *0   #0   !@     $   &      4%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,C4Z,#8Z,#8@,#@Z,C,Z,3(   .@
M 0 #     ?__  "@ @ $     0  !+N@ P $     0   6,         !@$#
M  ,    !  8   $:  4    !   !'@$;  4    !   !)@$H  ,    !  (
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M*"@H*"@H*/_  !$( 14#L@,!(@ "$0$#$0'_Q  <  $  @(# 0
M    !P@%!@$"! /_Q !7$  ! P("! 8*#@<'! $$ P !  (#! 4&$0<2(3$3
M05%A<8$(%"(V<W21H;&R%1<R,S4W0E)58I*SP=$6(S14<I3")%."@X23TB5#
M=:+P1$5C\:/AXO_$ !L!  (# 0$!               $ @,&!0$'_\0 .!$
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M@@C,$<:J::ZG9IOKNCQ5O*.41%X6A$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1
M!$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1
M!$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1
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M\U_)'BGGL;/@N^>&C]4J!E//8V?!=[\-'ZI5UO9.+M'O4?C]"8T1$H;((B(
MX>X,8YSCDT#,GD54-)V(G8DQ;5U+7YTT)X" <6HTG;UG,]:G;3'B0V#",S('
M 5=;G3Q[=K00=9WD](574Q3'O,WOFIRU1'S?\!2:[1Y(-%8O)CRN#7&J(X^
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M,?5/&.;T*P]DO-#>[?'6VRH9/ _C:=K3R$<1YDM*#B:O1Z^O5K\/)^!D$1%
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ML7@Y?2U3HH*[)/\ ;;%X.7TM4ZNT);O[I+X?5$,*P'8XY_HW=>3ML>H%7]6
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M:FSL:O?<0=$']:8L[+,SM/O</C]&3@B(E#:GCO/P/7> D]4JF+_=NZ5<Z\_
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MG#,V2CIXG*;\/7^W8@H&5=KJ631N&UH/=,/(X<15-UE\,8AN&&[G'6VR9S'
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MSJ:=X<PN&1]R!N6OHB]2QR%YS<Y.;[^9;_ ?>1A__P ?!]VU9U8+ ?>1A_\
M\?!]VU9U)/J;ZGV<?)!1#V2'>_:?&CZA4O*(>R0[W[3XT?4*E5VD*[G[K/\
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M-/SQE^+. %RB*LZ(1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0
M1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0
M1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0
M1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 (!&1&87S
MX"+,'@H\QQZH1$!@^B(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B
M "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B
M "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B
A "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g78153g0606101109372.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g78153g0606101109372.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D , # 2(  A$! Q$!_\0
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E2[R,YQZ98GBBBL<0^6\5HK_HCIPB4[2EJ[+7YLMT445RG>?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
